The system’s workflow provides the flexibility to analyze data in as few as eight hours, or to generate in excess of 1 gigabase per run in slightly over a day.
MiSeq utilises Illumina’s TruSeq chemistry to optimize run conditions to suit their particular applications.
Illumina president and CEO Jay Flatley said MiSeq improves cycle times and simplifies sample preparation, to deliver next-generation sequencing to researchers who currently use capillary electrophoresis (CE) sequencers.
"The platform will enable applications such as amplicon sequencing, clone checking, small genome sequencing, ChIP-Seq, and RNA-Seq, all with a single, integrated instrument and at a fraction of current costs and time,” Flatley said.